GLP-1 Weight Loss in Omaha (2026)

Omaha at a Glance

About GLP-1 Access in Omaha

Omaha is the largest city in Nebraska, located in Nebraska with a population of approximately 486,000. Telehealth is legal in Nebraska, and licensed GLP-1 providers can prescribe semaglutide or tirzepatide and ship directly to Omaha ZIP codes. Prices, formulary availability, and specific provider state coverage vary — confirm with the provider before starting.

The Omaha metro area brings the wider telehealth-serviceable population to roughly 1,001,010 residents, extending beyond the city's 486,051 city-proper population.

Nebraska's adult obesity rate is approximately 37.6% based on CDC Behavioral Risk Factor Surveillance System data^[2], and state rankings are published in CDC's Adult Obesity Facts^[3]. Nebraska ranks #17 of 50 states for adult obesity prevalence — near the national middle — and telehealth gives Omaha residents a fast, private alternative to scheduling with a local obesity-medicine specialist. Before starting treatment, it's worth understanding what the clinical trials actually showed about GLP-1 side effects.

Nebraska Medicaid does not currently cover GLP-1s for weight loss alone (Diabetes only), which is why cash-pay compounded semaglutide or tirzepatide — averaging $189/month — is the realistic path for most Omaha residents seeking obesity treatment outside a type 2 diabetes diagnosis.

Looking beyond Omaha? See all GLP-1 providers in Nebraska, or read our Nebraska Medicaid GLP-1 coverage & prior-authorization guide.

Browse by Medication

Browse all 338 providers with undisclosed coverage on the Nebraska page →

In-Person vs Telehealth in Omaha

Patients in Omaha have two main paths to GLP-1 treatment: an in-person obesity medicine or bariatric program, or a licensed telehealth provider that ships to Nebraska addresses. In-person programs are generally preferable for patients with complex medical needs, those pursuing bariatric surgery, or patients whose insurance covers a brand-name anti-obesity GLP-1 and requires in-person documentation. Telehealth is generally preferable for patients seeking cash-pay compounded semaglutide or tirzepatide from a 503A compounding pharmacy^[5]. Medicaid and commercial insurance coverage of anti-obesity GLP-1s in Nebraska varies by plan^[4].

In-person weight-management clinics in Omaha (59 in our directory)

From the NPI registry, cross-checked against obesity-medicine and bariatric taxonomy codes — mostly endocrinology, diabetes & metabolism.

• Amy Neumeister — Endocrinology, Diabetes & Metabolism, 988102 Nebraska Medical Ctr
• Andjela Drincic — Endocrinology, Diabetes & Metabolism, 119 N 51st St Ste 100
• Anery Patel — Endocrinology, Diabetes & Metabolism, Emile 42nd St
• Anupam Kotwal — Endocrinology, Diabetes & Metabolism, Emile @ 42nd St
• Brian Boerner — Endocrinology, Diabetes & Metabolism, Emile At 42nd St
• Brianna Johnson-Rabbett — Endocrinology, Diabetes & Metabolism, Emile @ 42nd St
• Claire Baker — Endocrinology, Diabetes & Metabolism, 7831 Chicago Court
• Cyrus Desouza — Endocrinology, Diabetes & Metabolism, 988095 Nebraska Medical Ctr

Browse all 59 Omaha clinics in the directory →

Cost of GLP-1 Medications in Omaha

Brand-name Wegovy in Omaha typically costs $1,349/month without insurance, while Zepbound runs $1,086/month. Compounded semaglutide through telehealth providers averages $189/month in Nebraska, representing savings of more than $13,000 per year. For a full breakdown of every low-cost option, read our cheapest way to get GLP-1s without insurance guide. If you're deciding between the two paths, see our compounded vs. branded GLP-1 decision guide.

Other Cities in Nebraska

Comparing options beyond Omaha? GLP-1 telehealth providers ship statewide, so these Nebraska cities have their own dedicated pricing and provider breakdowns:

Frequently Asked Questions